Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative ColitisShannon Telesco, Linda E. Greenbaum, Jewel Johanns et al.|Gastroenterology|2018Cited by 73
Prediction of Non-Response to Anti-Tnf Therapy in Ulcerative Colitis: Implications for Patient Stratification for IBD Trials and Novel Treatment ParadigmsShannon Telesco, Carrie Brodmerkel, Linda E. Greenbaum et al.|Gastroenterology|2017Cited by 1